Clinico-pathological features and somatic gene alterations in refractory ceramic fibre-induced murine mesothelioma reveal mineral fibre-induced mesothelioma identities

Carcinogenesis

Volumn 28, Issue 7, 2007, Pages 1599-1605

  Andujar, Pascal ^a,b   Lecomte, Céline ^c,i   Renier, Annie ^c,d   Fleury Feith,, Jocelyne ^c,e,f   Kheuang, Laurence ^a,b   Daubriac,, Julien ^c,d   Janin, Anne ^g,h   Jaurand, Marie Claude ^c,d  

^a INSERM U955   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c FONDATION JEAN DAUSSET CEPH   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔPITAL TENON   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g INSERM   (France)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ UNIVERSITÉ DU HAVRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; CYCLIN DEPENDENT KINASE INHIBITOR 2B; MINERAL FIBER; ONCOPROTEIN; PROTEIN INK4; PROTEIN NF2; PROTEIN P16INK4A; PROTEIN P19; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CANCER CELL CULTURE; CERAMICS; CHEMICAL CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; GENE DELETION; GENE INACTIVATION; GENE INSERTION; GENE LOCUS; HISTOPATHOLOGY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PERITONEUM MESOTHELIOMA; POINT MUTATION; PRIORITY JOURNAL;

ANIMALS; ASCITES; CELLS, CULTURED; CERAMICS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR PROTEINS; DISEASE MODELS, ANIMAL; MESOTHELIOMA; MICE; MICE, KNOCKOUT; MINERAL FIBERS; NEUROFIBROMIN 2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34547741626     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm023     Document Type: Article

References (38)

1. Pasetto,R. et al. (2005) Mesothelioma associated with environmental exposures. Med. Lav., 96, 330-337.
2. Robinson,B.W. et al. (2005) Advances in malignant mesothelioma. N. Engl. J. Med., 353, 1591-1603.
3. IARC, (2002) Man-made mineral fibres. IARC Monographs on the Evaluation of Carcinogenic Risky to Humans, Vol. 81, IARC, Lyon.
4. Cowie,H.A. et al. (2001) An epidemiological study of the respiratory health of workers in the European refractory ceramic fibre industry. Occup. Environ. Med., 58, 800-810.
5. Mast,R.W. et al. (1995) Studies on the chronic toxicity (inhalation) of four types of refractory ceramic fiber in male fischer 344 rats. Inhal. Toxicol., 7, 425-467.
6. Mast,R.W. et al. (1995) Multiple-dose chronic inhalation toxicity study of size-separated kaolin refractory ceramic fiber in male fisher 344 rats. Inhal. Toxicol., 7, 469-502.
7. McConell,E.E. et al. (1995) Chronic inhalation study of a kaolirt-based refractory ceramic fiber in Sytian golden hamsters. Inhal. Toxicol., 7, 503-532.
8. Donaldson, K. et al. (1995) Superoxide anion release by alveolar macrophages exposed to respirable industrial fibres: Modifying effect of fibre opsonisation. Exp. Toxicol. Pathol., 47, 229-231.
9. Dopp,E. et al. (1997) Induction of micronuclei, hyperdiploidy and chromosomal breakage affecting the centric/pericentric regions of chromosomes 1 and 9 in human amniotic fluid cells after treatment with asbestos and ceramic fibers. Mutat. Res., 377, 77-87.
10. Hart,G.A. et al. (1992) Cytotoxicity of refractory ceramic fibres to Chinese hamster ovary cells in culture. Toxicol. In Vitro, 6 317-326.
11. Ohyama,M. et al. (2000) The chemiluminescent response from human monocyte-derived macrophages exposed to various mineral fibers of different sizes. Ind Health, 38, 289-293.
12. Wang,Q.E. et al. (1999) Biological effects of man-made mineral fibers (I)-reactive oxygen species production and calcium homeostasis in alveolar macrophages. Ind Health, 37, 62-67.
13. Wang,Q.E. et al. (1999) Biological effects of man-made mineral fibers (II)- their genetic damages examined by in vitro assay. Ind. Health, 37, 342-347.
14. Kociok,N. et al. (1999) DNA fingerprint analysis reveals differences in mutational patterns in experimentally induced rat peritoneal tumors, depending on the type of environmetal mutagen. Cancer Genet. Cytogenet., 111, 71-76.
15. Unfried,K. et al. (1997) P53 mutations in tumours induced by intraperitoneal injection of crocidolite asbestos and benzo[a]pyrene in rats. Exp. Toxicol. Pathol., 49, 181-187.
16. Unfried,K. et al. (2002) Distinct spectrum of mutations induced by crocidolite asbestos: Clue for 8-hydroxydeoxyguanosine-dependent mutagenesis in vivo. Cancer Res., 62, 99-104.
17. Ni,Z. et al. (2000) Analysis of K-ras and p53 mutations in mesotheliomas from humans and rats exposed to asbestos. Mutat. Res. 468, 87-92.
18. Jackson,M.A. et al. (2006) Genetic alterations in cancer knowledge system: Analysis of gene mutations in mouse and human liver and lung tumors. Toxicol. Sci., 90, 400-418.
19. Olivier,M. et al. (2004) TP53 mutation spectra and load: A tool for generating hypotheses on the etiology of cancer. IARC Sci. Publ. 157, 247-270.
20. Staib,F. et al. (2003) TP53 and liver carcinogenesis. Hum. Mutat., 21, 201-216.
21. Murthy,S.S. et al. (1999) Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J. Cell. Physiol., 180, 150-157.
22. Fleury-Feith,J. et al. (2003) Hemizygosity of Nf2 is associated with increased susceptibility to asbestos-induced peritoneal tumours. Oncogene, 22, 3799-3805.
23. Lecomte,C. et al. (2005) Similar tumor suppressor gene alteration profiles in asbestos-induced murine and human mesothelionia. Cell Cycle, 4, 1862-1869.
24. Giovannini,M. et al. (2000) Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. Genes Dev., 14, 1617-1630.
25. AVMA (1993) 1993 report of the AVMA panel on euthanasia. J. Am. Vet. Med. Assoc., 202, 230-249.
26. Zhuang,S.M. et al. (1998) Inactivations of p16INK4a-alpha, p16INK4a-beta and p15INK4b genes'in 2′,3′-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas. Oncogene, 16, 803-808.
27. Broers,A.E., et al. (2003) Interleukin-7 improves T-cell recovery after experimental T-cell-depleted bone marrow transplantation in T-cell-deficient mice by strong expansion of recent thymic emigrants. Blood, 102, 1534-1540.
28. Giulietti,A. et al. (2001) An overview of real-time quantitative PCR: Applications to quantify cytokine gene expression. Methods, 25, 386-401.
29. Livak,K.J. et al.(2001) Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) method. Methods, 25, 402-408.
30. Churg,A. et al. (2004) Mesothelioma. In: William,D.,Travis,E.B.,Konrad Müller-Hermelink,H. and Harris,Curtis C. (eds) Pathology and Genetics of the Lung, Pleura, Thymus and Heart WHO Publications, Lyon, Vol. 10, pp. 128-140.
31. Lee,K. et al. (1984) Biological studies on inorganic potassium titanate fibers. In Biological Effects of Man-Made Mineral Fibers. Proceedings of a WHO/IARC Conference, Copenhagen, World Health Organization, Vol. 2, pp. 323-333.
32. Davis,M.R. et al. (1992) Establishment of a murine model of malignant mesothelioma. Int. J. Cancer, 52, 881-886.
33. Smith,D.M. et al. (1987) Long-term health effects in hamsters and rats exposed chronically to man-made vitreous fibres. Ann. Occup. Hyg., 31, 731-754.
34. GAC database(2006) Genetic alterations in cancer. http://dir-apps.niehs.nih.gov/gac/ (2 March 2007, date Last accessed).
35. Hartmann,A. et al. (1995) p53 gene mutations inside and outside of exons 5-8: The patterns differ in breast and other cancers. Oncogene 10, 681-688.
36. Nogales,F.F. et al. (2004) Multifocal intrafollicular granulosa cell tumor of the ovary associated with an unusual germline p53 mutation. Mod. Pathol., 17, 868-873.
37. Soussi,T. (2005) The p53 database. http://p53free.fr/ (2 March 2007, date Last accessed).
38. Borczuk,A.C. et al. (2006) Molecular profiling of malignant peritoneal mesothelioma identifies the ubiquitin-proteasome pathway as a therapeutic target in poor prognosis tumors, Oncogene, 26, 610-617.